This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Teladoc to Buy InTouch Health, Expand Reach in Virtual Care
by Zacks Equity Research
Teladoc (TDOC) to acquire InTouch Health and provide virtual health solutions ranging from critical to everyday care.
Teladoc Adds to its Services With Tailored Nutrition Plans
by Zacks Equity Research
Teladoc (TDOC) enhances its service portfolio with the addition of personalized diet programs.
Teladoc (TDOC) Up 73% Year to Date: Will the Rally Continue?
by Sapna Bagaria
Teladoc's (TDOC) presence in the growing telehealth industry with many deal wins and international expansion is likely to drive long-term growth.
Is Teladoc Health (TDOC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TDOC) Outperforming Other Medical Stocks This Year?
Teladoc Health, Inc. (TDOC) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Teladoc Health, Inc. (TDOC).
Is Teladoc Health (TDOC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TDOC) Outperforming Other Medical Stocks This Year?
Healthcare ETF (IHF) Tops in October: 5 Best Stocks
by Sweta Killa
Inside the best performing stocks of the top ETF of October.
Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Teladoc (TDOC) Q3 earning are likely to have benefited from increased membership and visits, and accretive effect of earlier acquisitions.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology
Should Teladoc Worry About Amazon's Virtual Healthcare Move?
by Zacks Equity Research
Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology.
Teladoc Gains on Growing Acceptance for TeleHealth Services
by Zacks Equity Research
Teladoc's (TDOC) extensive ecosystem and infrastructure poise it well for long-term growth in the expanding telehealth industry.
Teladoc Up 33% Year to Date: Will the Momentum Continue?
by Zacks Equity Research
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of -2.50% and 0.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More
by Zacks Equity Research
Healthcare stocks like HUM, AMED, CRL, TDOC and PRAH are likely to benefit from higher membership and revenues in the second quarter.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?
by Zacks Equity Research
Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.
Why Should You Retain Teladoc (TDOC) in Your Portfolio?
by Zacks Equity Research
Banking on improving revenues and strategic acquisitions, Teladoc (TDOC) holds great potential to garner benefits for investors.
Teladoc (TDOC) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health (TDOC) Surpasses Estimates in Q1 Earnings
by Zacks Equity Research
Teladoc's (TDOC) loss in the first quarter can be attributed to higher operating expenses than revenues.
Teladoc (TDOC) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Teladoc's (TDOC) Q1 earnings should benefit from increase in revenues, partly offset by rise in expenses.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc's Partnership to Form Pediatric Telehealth Platform
by Zacks Equity Research
Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.
Why Is Teladoc (TDOC) Down 16.6% Since Last Earnings Report?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.